Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms

Diagn Microbiol Infect Dis. 1984 Jun;2(3):255-60. doi: 10.1016/0732-8893(84)90039-7.

Abstract

Thirty-eight isolates of gram-negative bacilli resistant to four new beta-lactam antibiotics, aztreonam, moxalactam, ceftazidime, and cefoperazone, were tested in the presence of two beta-lactam inhibitors, clavulanic acid and sulbactam. Microorganisms tested included 22 isolates of Pseudomonas species, 5 of Klebsiella species, and 11 of Enterobacter species. A 2- to 10-fold decrease in minimum inhibitory concentration was noted when antibiotics and beta-lactamase inhibitors were combined compared to antibiotics alone. Four strains of Pseudomonas aeruginosa showed increased resistance to the combination of antibiotics and beta-lactamase inhibitors.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Clavulanic Acid
  • Clavulanic Acids / pharmacology*
  • Drug Resistance, Microbial
  • Enterobacter / drug effects
  • Gram-Negative Bacteria / drug effects*
  • Humans
  • Klebsiella / drug effects
  • Microbial Sensitivity Tests
  • Penicillanic Acid / pharmacology*
  • Pseudomonas / drug effects
  • Sulbactam
  • beta-Lactamase Inhibitors*

Substances

  • Anti-Bacterial Agents
  • Clavulanic Acids
  • beta-Lactamase Inhibitors
  • Clavulanic Acid
  • Penicillanic Acid
  • Sulbactam